Literature DB >> 31018975

Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.

Barbara Cappelli1,2, Fernanda Volt3,2, Karina Tozatto-Maio3,2,4, Graziana Maria Scigliuolo3,2, Alina Ferster5, Sophie Dupont6, Belinda Pinto Simões4, Amal Al-Seraihy7, Mahmoud D Aljurf8, Fahad Almohareb8, Cristina Belendez9, Susanne Matthes10, Nathalie Dhedin11, Corinne Pondarre12, Jean-Hugues Dalle13, Yves Bertrand14, Jean Pierre Vannier15, Mathieu Kuentz12, Patrick Lutz16, Gérard Michel17, Hanadi Rafii3,2, Benedicte Neven18, Marco Zecca19, Peter Bader20, Marina Cavazzana21,22, Myriam Labopin23, Franco Locatelli24, Alessandra Magnani21, Annalisa Ruggeri3,2,24, Vanderson Rocha25, Françoise Bernaudin12, Josu de La Fuente26, Selim Corbacioglu27, Eliane Gluckman3,2.   

Abstract

Year:  2019        PMID: 31018975      PMCID: PMC6959194          DOI: 10.3324/haematol.2019.216788

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.

Authors:  Léon Tshilolo; George Tomlinson; Thomas N Williams; Brígida Santos; Peter Olupot-Olupot; Adam Lane; Banu Aygun; Susan E Stuber; Teresa S Latham; Patrick T McGann; Russell E Ware
Journal:  N Engl J Med       Date:  2018-12-01       Impact factor: 91.245

2.  Assessing Costs, Benefits, and Risks in Chronic Disease: Taking the Long View.

Authors:  Carla Saenz; John F Tisdale
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-14       Impact factor: 5.742

3.  Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis.

Authors:  Michael R DeBaun; Djamila L Ghafuri; Mark Rodeghier; Poulami Maitra; Shruti Chaturvedi; Adetola Kassim; Kenneth I Ataga
Journal:  Blood       Date:  2018-12-10       Impact factor: 22.113

4.  Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.

Authors:  Shalini Shenoy; Emanuele Angelucci; Staci D Arnold; K Scott Baker; Monica Bhatia; Dorine Bresters; Andrew C Dietz; Josu De La Fuente; Christine Duncan; Javid Gaziev; Allison A King; Michael A Pulsipher; Angela R Smith; Mark C Walters
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-05       Impact factor: 5.742

5.  Survival in adults with sickle cell disease in a high-income setting.

Authors:  Kate Gardner; Abdel Douiri; Emma Drasar; Marlene Allman; Anne Mwirigi; Moji Awogbade; Swee Lay Thein
Journal:  Blood       Date:  2016-07-20       Impact factor: 22.113

6.  Are the risks of treatment to cure a child with severe sickle cell disease too high?

Authors:  Mariane de Montalembert; Valentine Brousse; Subarna Chakravorty; Antonio Pagliuca; John Porter; Paul Telfer; Ajay Vora; David C Rees
Journal:  BMJ       Date:  2017-11-23

7.  Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.

Authors:  Carlton Dampier; Petra LeBeau; Seungshin Rhee; Susan Lieff; Karen Kesler; Samir Ballas; Zora Rogers; Winfred Wang
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

8.  Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.

Authors:  Emanuele Angelucci; Susanne Matthes-Martin; Donatella Baronciani; Françoise Bernaudin; Sonia Bonanomi; Maria Domenica Cappellini; Jean-Hugues Dalle; Paolo Di Bartolomeo; Cristina Díaz de Heredia; Roswitha Dickerhoff; Claudio Giardini; Eliane Gluckman; Ayad Achmed Hussein; Naynesh Kamani; Milen Minkov; Franco Locatelli; Vanderson Rocha; Petr Sedlacek; Frans Smiers; Isabelle Thuret; Isaac Yaniv; Marina Cavazzana; Christina Peters
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

9.  Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.

Authors:  Poulami Maitra; Melissa Caughey; Laura Robinson; Payal C Desai; Susan Jones; Mehdi Nouraie; Mark T Gladwin; Alan Hinderliter; Jianwen Cai; Kenneth I Ataga
Journal:  Haematologica       Date:  2017-01-19       Impact factor: 9.941

10.  Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.

Authors:  Staci D Arnold; Ruta Brazauskas; Naya He; Yimei Li; Richard Aplenc; Zhezhen Jin; Matt Hall; Yoshiko Atsuta; Jignesh Dalal; Theresa Hahn; Nandita Khera; Carmem Bonfim; Navneet S Majhail; Miguel Angel Diaz; Cesar O Freytes; William A Wood; Bipin N Savani; Rammurti T Kamble; Susan Parsons; Ibrahim Ahmed; Keith Sullivan; Sara Beattie; Christopher Dandoy; Reinhold Munker; Susana Marino; Menachem Bitan; Hisham Abdel-Azim; Mahmoud Aljurf; Richard F Olsson; Sarita Joshi; Dave Buchbinder; Michael J Eckrich; Shahrukh Hashmi; Hillard Lazarus; David I Marks; Amir Steinberg; Ayman Saad; Usama Gergis; Lakshmanan Krishnamurti; Allistair Abraham; Hemalatha G Rangarajan; Mark Walters; Joseph Lipscomb; Wael Saber; Prakash Satwani
Journal:  Haematologica       Date:  2017-08-17       Impact factor: 9.941

View more
  9 in total

1.  Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.

Authors:  Lisa V E Oostenbrink; Emma S Pool; Cornelia M Jol-van der Zijde; Anja M Jansen-Hoogendijk; Carly Vervat; Astrid G S van Halteren; Robbert G M Bredius; Frans J W Smiers; Maarten J D van Tol; Marco W Schilham; Arjan C Lankester; Alexander B Mohseny
Journal:  Bone Marrow Transplant       Date:  2021-05-03       Impact factor: 5.483

2.  Hematopoietic cell transplantation for sickle cell disease: updates and future directions.

Authors:  Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Evidence-Based Minireview: In young children with severe sickle cell disease, do the benefits of HLA-identical sibling donor HCT outweigh the risks?

Authors:  Niketa Shah; Lakshmanan Krishnamurti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

4.  Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022.

Authors:  John A Snowden; Isabel Sánchez-Ortega; Selim Corbacioglu; Grzegorz W Basak; Christian Chabannon; Rafael de la Camara; Harry Dolstra; Rafael F Duarte; Bertram Glass; Raffaella Greco; Arjan C Lankester; Mohamad Mohty; Bénédicte Neven; Régis Peffault de Latour; Paolo Pedrazzoli; Zinaida Peric; Ibrahim Yakoub-Agha; Anna Sureda; Nicolaus Kröger
Journal:  Bone Marrow Transplant       Date:  2022-05-19       Impact factor: 5.174

5.  The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.

Authors:  Eliane Gluckman; Josu de la Fuente; Barbara Cappelli; Graziana M Scigliuolo; Fernanda Volt; Karina Tozatto-Maio; Vanderson Rocha; Mina Tommaso; Farah O'Boyle; Frans Smiers; Claudia Bettoni Da Cunha-Riehm; Elisabetta Calore; Sonia Bonanomi; Stelios Graphakos; Anna Paisiou; Michael H Albert; Annalisa Ruggeri; Marco Zecca; Arjan C Lankester; Selim Corbacioglu
Journal:  Bone Marrow Transplant       Date:  2020-03-10       Impact factor: 5.483

6.  Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.

Authors:  Lakshmanan Krishnamurti; Staci D Arnold; Ann Haight; Allistair Abraham; Gregory Mt Guilcher; Tami John; Nitya Bakshi; Shalini Shenoy; Karen Syrjala; Paul L Martin; Sonali Chaudhury; Gretchen Eames; Olusola Festus Olowoselu; Matthew Hsieh; Josu De La Fuente; Kimberly A Kasow; Elizabeth Stenger; Anne Mertens; Fuad El-Rassi; Peter Lane; Bronwen E Shaw; Lillian Meacham; David Archer
Journal:  JMIR Res Protoc       Date:  2022-07-06

7.  Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease.

Authors:  Alexander Ngwube; Niketa Shah; Kamar Godder; David Jacobsohn; Monica L Hulbert; Shalini Shenoy
Journal:  Blood Adv       Date:  2020-08-25

8.  Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?

Authors:  Laurence Rozen; Denis F Noubouossie; Laurence Dedeken; Phu Quoc Lê; Alina Ferster; Anne Demulder
Journal:  J Clin Med       Date:  2019-10-26       Impact factor: 4.241

Review 9.  Considerations in Preparative Regimen Selection to Minimize Rejection in Pediatric Hematopoietic Transplantation in Non-Malignant Diseases.

Authors:  Robert J Hayashi
Journal:  Front Immunol       Date:  2020-10-19       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.